Eribulin Mesylate Solution
Product Images NDC 68001-656

Product Visual Gallery

This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Eribulin Mesylate (NDC 68001-656). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Bluepoint Laboratories, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Eribulin Mesylate 1mg-2ml Carton 04-2025 (Eribulin Mesylate 1mg 2ml Carton 04 2025)

This text appears to be a description of a medical product labeled as "Eribulin Mesylate Injection." It is mentioned to be a cytotoxic agent administered intravenously, with specific dosage information provided. The product is in single-dose vials and should be discarded if unused. Additional prescribing information is available to guide its use. Please consult the accompanying Prescribing Information for further details.*

FDA Label Image

Eribulin Mesylate 1mg-2ml Vial Label 04-2025 (Eribulin Mesylate 1mg 2ml Vial Label 04 2025)

This text provides information about a sterile solution of Eribulin Mesylate for injection. It includes instructions on storage conditions, dosage, and manufacturer details. The solution is a cytotoxic agent and should only be used as directed. The text also mentions single-dose vial packaging and provides a revision date.*

FDA Label Image

Structural Formula (Eri04 0004 01)

FDA Label Image

Figure 1 (Eri04 0004 02)

FDA Label Image

Figure 2 (Eri04 0004 03)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.